211 related articles for article (PubMed ID: 26329788)
1. Prediction of the Clinical Risk of Drug-Induced Cholestatic Liver Injury Using an In Vitro Sandwich Cultured Hepatocyte Assay.
Susukida T; Sekine S; Nozaki M; Tokizono M; Ito K
Drug Metab Dispos; 2015 Nov; 43(11):1760-8. PubMed ID: 26329788
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a Drug-Induced, Bile Acid-Dependent Hepatotoxicity Model Using HepaRG Cells.
Susukida T; Sekine S; Nozaki M; Tokizono M; Oizumi K; Horie T; Ito K
J Pharm Sci; 2016 Apr; 105(4):1550-60. PubMed ID: 26952880
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of bile salt transport by drugs associated with liver injury in primary hepatocytes from human, monkey, dog, rat, and mouse.
Zhang J; He K; Cai L; Chen YC; Yang Y; Shi Q; Woolf TF; Ge W; Guo L; Borlak J; Tong W
Chem Biol Interact; 2016 Aug; 255():45-54. PubMed ID: 27000539
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes.
Oorts M; Baze A; Bachellier P; Heyd B; Zacharias T; Annaert P; Richert L
Toxicol In Vitro; 2016 Aug; 34():179-186. PubMed ID: 27046439
[TBL] [Abstract][Full Text] [Related]
5. Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes.
Ogimura E; Sekine S; Horie T
Biochem Biophys Res Commun; 2011 Dec; 416(3-4):313-7. PubMed ID: 22108051
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Activation of Cholestatic Drug-Induced Bile Acid-Dependent Toxicity in Human Sandwich-Cultured Hepatocytes.
Ogimura E; Tokizono M; Sekine S; Nakagawa T; Bando K; Ito K
J Pharm Sci; 2017 Sep; 106(9):2509-2514. PubMed ID: 28465153
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of bile canalicular network formation in rat sandwich cultured hepatocytes by drugs associated with risk of severe liver injury.
Takemura A; Izaki A; Sekine S; Ito K
Toxicol In Vitro; 2016 Sep; 35():121-30. PubMed ID: 27256767
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte-based in vitro model for assessment of drug-induced cholestasis.
Chatterjee S; Richert L; Augustijns P; Annaert P
Toxicol Appl Pharmacol; 2014 Jan; 274(1):124-36. PubMed ID: 24211272
[TBL] [Abstract][Full Text] [Related]
9. Development of an in vitro cholestatic drug-induced liver injury evaluation system using HepG2-hNTCP-C4 cells in sandwich configuration.
Sakai Y; Okumura H; Iwao T; Watashi K; Ito K; Matsunaga T
Toxicol In Vitro; 2019 Dec; 61():104619. PubMed ID: 31394163
[TBL] [Abstract][Full Text] [Related]
10. In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Dawson S; Stahl S; Paul N; Barber J; Kenna JG
Drug Metab Dispos; 2012 Jan; 40(1):130-8. PubMed ID: 21965623
[TBL] [Abstract][Full Text] [Related]
11. Inter-individual differences in the susceptibility of primary human hepatocytes towards drug-induced cholestasis are compound and time dependent.
Parmentier C; Hendriks DFG; Heyd B; Bachellier P; Ingelman-Sundberg M; Richert L
Toxicol Lett; 2018 Oct; 295():187-194. PubMed ID: 29913214
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Drug-Induced Liver Injury Prediction: Criteria Optimization of Efflux Transporter IC50 and Physicochemical Properties.
Yucha RW; He K; Shi Q; Cai L; Nakashita Y; Xia CQ; Liao M
Toxicol Sci; 2017 Jun; 157(2):487-499. PubMed ID: 28369588
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity: Results from 152 marketed drugs with known liver injury profiles.
Zhang J; Doshi U; Suzuki A; Chang CW; Borlak J; Li AP; Tong W
Chem Biol Interact; 2016 Aug; 255():3-11. PubMed ID: 26581450
[TBL] [Abstract][Full Text] [Related]
14. The C-DILI™ Assay: An Integrated In Vitro Approach to Predict Cholestatic Hepatotoxicity.
Jackson JP; Brouwer KR
Methods Mol Biol; 2019; 1981():75-85. PubMed ID: 31016648
[TBL] [Abstract][Full Text] [Related]
15. Detection of Drug-Induced Cholestasis Potential in Sandwich-Cultured Human Hepatocytes.
Deferm N; Richert L; Van Brantegem P; De Vocht T; Qi B; de Witte P; Bouillon T; Annaert P
Methods Mol Biol; 2019; 1981():335-350. PubMed ID: 31016665
[TBL] [Abstract][Full Text] [Related]
16. A Novel MicroRNA Signature for Cholestatic Drugs in Human Hepatocytes and Its Translation into Novel Circulating Biomarkers for Drug-Induced Liver Injury Patients.
López-Riera M; Conde I; Castell JV; Jover R
Toxicol Sci; 2020 Feb; 173(2):229-243. PubMed ID: 31198949
[TBL] [Abstract][Full Text] [Related]
17. Perturbation of bile acid homeostasis is an early pathogenesis event of drug induced liver injury in rats.
Yamazaki M; Miyake M; Sato H; Masutomi N; Tsutsui N; Adam KP; Alexander DC; Lawton KA; Milburn MV; Ryals JA; Wulff JE; Guo L
Toxicol Appl Pharmacol; 2013 Apr; 268(1):79-89. PubMed ID: 23360887
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Assay System to Detect Drug-Induced Bile Acid-Dependent Cytotoxicity Using Hepatocytes.
Takemura A; Ito K
Methods Mol Biol; 2022; 2544():119-127. PubMed ID: 36125714
[TBL] [Abstract][Full Text] [Related]
19. Role of Organic Solute Transporter Alpha/Beta in Hepatotoxic Bile Acid Transport and Drug Interactions.
Beaudoin JJ; Bezençon J; Sjöstedt N; Fallon JK; Brouwer KLR
Toxicol Sci; 2020 Jul; 176(1):34-35. PubMed ID: 32294204
[TBL] [Abstract][Full Text] [Related]
20. Establishment of an in vitro cholestasis risk assessment system using two-dimensional cultured HepaRG cells and 12 bile acids.
Koga T; Takeuchi K; Umehara K
J Toxicol Sci; 2023; 48(1):47-56. PubMed ID: 36599427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
